Skip to content

    GILEAD SCIENCES, INC.

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Trend
    EarningsRevenue
    $6.95B
    $7.54B
    $7.57B
    $6.67B
    $7.08B
    +1.8%
    $7.77B
    +3.0%
    $7.92B
    +4.7%
    $6.96B
    +4.4%
    Strengthening
    Operating Profit
    $2.64B
    $888.00M
    $2.45B
    $2.24B
    $2.47B
    -6.4%
    $3.33B
    +274.7%
    $1.98B
    -19.1%
    $2.59B
    +15.6%
    Strengthening
    Net Profit
    $1.61B
    $1.25B
    $1.78B
    $1.31B
    $1.96B
    +21.4%
    $3.05B
    +143.6%
    $2.18B
    +22.4%
    $2.02B
    +53.7%
    Strengthening
    EPS
    $1.29
    $1.00
    $1.06
    $1.57
    +21.7%
    $2.46
    +146.0%
    $1.63
    +53.8%
    Strengthening
    Other Income
    -$355.00M
    $306.00M
    -$36.00M
    -$328.00M
    $208.00M
    $569.00M
    +85.9%
    $349.00M
    $235.00M
    Strengthening
    Interest
    $237.00M
    $238.00M
    $248.00M
    $260.00M
    $254.00M
    +7.2%
    $256.00M
    +7.6%
    $254.00M
    +2.4%
    $240.00M
    -7.7%
    Stable
    Depreciation
    Profit before Tax
    $2.05B
    $956.00M
    $2.17B
    $1.65B
    $2.43B
    +18.3%
    $3.64B
    +280.9%
    $2.08B
    -4.2%
    $2.58B
    +56.5%
    Strengthening
    MarginsOPM
    38.0%
    11.8%
    32.4%
    33.5%
    34.9%
    -8.1%
    42.8%
    +263.8%
    25.0%
    -22.7%
    37.2%
    +10.8%
    Strengthening
    Tax
    21.3%
    -31.1%
    17.8%
    20.3%
    19.3%
    -9.7%
    16.2%
    -5.1%
    -128.5%
    21.7%
    +7.0%
    Weakening
    ReturnsROIC
    11.4%
    8.9%
    12.6%
    9.3%
    13.9%
    +21.4%
    21.6%
    +143.6%
    15.5%
    +22.4%
    14.3%
    +53.7%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$17.94B$11.63B$6.00B$5.34B$5.41B$6.08B$9.99B$7.56B$7.63B
    Short-Term Investments$12.15B$12.72B$1.41B$1.18B$973.00M$1.18B$0$68.00M$15.00M
    Total Current Assets$35.84B$30.30B$16.00B$14.77B$14.44B$16.09B$19.17B$18.34B$18.64B
    Net PP&E$4.01B$5.17B$5.61B$5.66B$5.98B$5.90B$5.93B$6.14B$5.64B
    Goodwill$4.12B$4.12B$8.11B$8.33B$8.31B$8.31B$8.31B$8.31B$8.31B
    Intangibles$15.74B$13.79B$33.13B$33.45B$28.89B$26.45B$19.95B$16.98B$16.38B
    Total Assets$63.67B$61.63B$68.41B$67.95B$63.17B$62.13B$58.99B$59.02B$56.28B
    LiabilitiesTotal Current Liabilities$10.61B$9.76B$11.40B$11.61B$11.24B$11.28B$12.00B$11.81B$9.48B
    Short-Term Debt$2.75B$2.50B$2.76B$1.52B$2.27B$1.80B$1.81B$2.81B$1.31B
    Long-Term Debt$24.57B$22.09B$28.64B$25.18B$22.96B$23.19B$24.90B$22.13B$20.86B
    Long-Term Leases$626.00M$608.00M$489.00M$467.00M$546.00M$498.00M$503.00M
    Total Liabilities$42.14B$38.98B$50.19B$46.89B$41.96B$39.38B$39.75B$36.41B$32.85B
    EquityCommon Stock & APIC$1.00M$1.00M$1.00M$1.00M$1.00M$1.00M$1.00M$1.00M$1.00M
    Retained Earnings$19.02B$19.39B$14.38B$16.32B$15.69B$16.30B$11.50B$13.73B$14.13B
    Total Equity$21.39B$22.52B$18.20B$21.07B$21.24B$22.83B$19.33B$22.70B$23.52B
    HighlightsNet Cash / (Debt)$2.77B-$241.00M-$23.99B-$20.18B-$18.84B-$17.72B-$16.72B-$17.30B-$14.53B

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$8.40B$9.14B$8.17B$11.38B$9.07B$8.01B$10.83B$10.02B$10.81B
    Cash from Investing$14.36B-$7.82B-$14.62B-$3.13B-$2.47B-$2.27B-$3.45B-$4.79B-$2.61B
    Cash from Financing-$12.32B-$7.63B$770.00M-$8.88B-$6.47B-$5.13B-$3.43B-$7.75B-$8.56B
    SummaryCapital Expenditure-$924.00M-$825.00M-$650.00M-$579.00M-$728.00M-$585.00M-$523.00M-$563.00M-$576.00M
    Free Cash Flow$7.48B$8.32B$7.52B$10.80B$8.34B$7.42B$10.30B$9.46B$10.23B
    FCF Margin33.8%37.1%30.5%39.6%30.6%27.4%35.8%32.1%34.4%